10.07.2012 Views

CONTENTS - L'Oréal

CONTENTS - L'Oréal

CONTENTS - L'Oréal

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

LATIN AMERICA &<br />

THE CARRIBEAN<br />

Argentina<br />

Environmental Biology<br />

María Valeria LARA, 30, PhD in Biological Sciences,<br />

is a post-doctoral researcher and lecturer in plant<br />

biochemistry at the National University of Rosario in<br />

Argentina. Her research focuses on the effect of<br />

environmental and climatic stress on the process of<br />

photosynthesis and in particular on the development of<br />

crops that can use water more efficiently under drought<br />

conditions.<br />

The safeguard of the world’s water resources is<br />

dependent on research in this area: currently some 40%<br />

of the world’s food crops are grown under artificial<br />

irrigation and 70% of the water drawn by humans from<br />

freshwater sources is used for agriculture. Plants<br />

control water-loss and CO2 intake from their leaf<br />

surface through the action of leaf guard cells. These<br />

cells have the capacity to open and close the leaf<br />

stomata (pores) by changing shape in response to<br />

environmental conditions such as light and water<br />

stress. A specific enzyme (NADP-malic enzyme) is<br />

supposed to be involved in this process.<br />

During her fellowship, Dr Lara plans to transfer the<br />

maize gene – this species use a photosynthetic pathway<br />

known as C4 – which codes for this enzyme into tobacco<br />

plants, which use a different photosynthetic pathway<br />

(C3), to see if this specific enzyme could be used as a<br />

mechanism to make other C3 plants, including<br />

important food crops such as wheat, more resistant to<br />

water stress.<br />

On her return to Argentina, Dr Lara will test her results<br />

on other plants, under differing environmental<br />

conditions, with the aim of developing drought-resistant<br />

crop plants with increased yield.<br />

Host institution: School of Biological Sciences,<br />

Washington State University, USA. �<br />

FELLOWS UNESCO-L’ORÉAL 2005<br />

Brazil<br />

Medical Science<br />

Michelle Lucinda DE OLIVEIRA, 33, a medical<br />

doctor, is currently working as an attending surgeon at<br />

department of Gastrointestinal Surgery at the Federal<br />

University of São Paulo, where she is doing postgraduate<br />

research in surgical hepatopancreaticobiliary field. Her<br />

research focus is on liver cancer and novel strategies to<br />

treat this disease.<br />

Cancer arising in the liver (primary liver cancer) is one of<br />

the commonest cancers in the world, with approximately<br />

one million new cases reported every year. The liver is<br />

also one of the main sites of secondary tumors<br />

originating from metastatic cancer cells. The liver is the<br />

only solid organ, which can regenerate and grow back to<br />

its normal size. Up to 70% of the liver can be safely<br />

removed, and it will fully regenerate within a few weeks.<br />

For this reason surgery remains the first line of<br />

treatment in many cases and the only chance of cure for<br />

patients with primary or secondary liver tumors. A<br />

frequently alternative strategy used prior to surgery is to<br />

occlude one major vein supplying blood to a large part of<br />

the liver (portal vein embolization) selectively causing<br />

liver atrophy and concomitant major regeneration in the<br />

part with intact blood supply. This strategy is very useful<br />

to enable safe resection of large liver volume (> 70% of<br />

the liver mass) containing cancer. However, how<br />

regeneration influences tumor growth in the remaining<br />

tissue and whether liver resection or portal vein<br />

embolization have similar effects is unknown.<br />

Dr de Oliveira wants to find out how liver resection and<br />

portal vein embolization influence tumor growth, and<br />

which growth factors produced by the liver are involved.<br />

The long-term goal is to enable safe resection of large<br />

liver volume while minimizing the risk of tumor<br />

recurrence after surgery.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!